null

Ragifilimab (Anti-GITR/TNFRSF18) Biosimilar Antibody

SKU:
HDBS0063
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
GITR
Reactivity:
Human
Host Species:
Chimeric Humanized
Isotype:
IgG4
€373
Frequently bought together:

Description

system_update_altDatasheet

Ragifilimab (Anti-GITR/TNFRSF18) Biosimilar Antibody (HDBS0063)

The Anti-GITR (TNFRSF18) Polyclonal Antibody (HDBS0063) is a vital tool for researchers studying the GITR (TNFRSF18) protein, a receptor involved in immune regulation and inflammation modulation. Raised in rabbits, this antibody exhibits high reactivity with human samples and has been validated for use in Western blot applications. By binding specifically to GITR (TNFRSF18), researchers can accurately detect and analyze this key protein in various cell types, making it a valuable asset for studies in immunology and cancer research.GITR (TNFRSF18) plays a crucial role in immune response modulation, making it a promising target for research on diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions.

Understanding the function of GITR (TNFRSF18) is essential for developing therapeutic strategies that manipulate immune responses effectively. The Anti-GITR (TNFRSF18) Polyclonal Antibody (HDBS0063) offers researchers a reliable tool to advance their understanding of this important protein and its implications in various disease contexts.